• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 4 个 mRNA 的风险模型预测经典型甲状腺乳头状癌患者的预后。

Prognostic prediction of patients having classical papillary thyroid carcinoma with a 4 mRNA-based risk model.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Minda Hospital of Hubei Minzu University, Enshi, Hubei, China.

出版信息

Medicine (Baltimore). 2024 Jun 7;103(23):e38472. doi: 10.1097/MD.0000000000038472.

DOI:10.1097/MD.0000000000038472
PMID:38847736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11155612/
Abstract

The dysregulation of protein-coding genes involved in various biological functions is closely associated with the progression of thyroid cancer. This study aimed to investigate the effects of dysregulated gene expressions on the prognosis of classical papillary thyroid carcinoma (cPTC). Using expression profiling datasets from the Cancer Genome Atlas (TCGA) database, we performed differential expression analysis to identify differentially expressed genes (DEGs). Cox regression and Kaplan-Meier analysis were used to identify DEGs, which were used to construct a risk model to predict the prognosis of cPTC patients. Functional enrichment analysis unveiled the potential significance of co-expressed protein-encoding genes in tumors. We identified 4 DEGs (SALL3, PPBP, MYH1, and SYNDIG1), which were used to construct a risk model to predict the prognosis of cPTC patients. These 4 genes were independent of clinical parameters and could be functional in cPTC carcinogenesis. Furthermore, PPBP exhibited a strong correlation with poorer overall survival (OS) in the advanced stage of the disease. This study suggests that the 4-gene signature could be an independent prognostic biomarker to improve prognosis prediction in cPTC patients older than 46.

摘要

涉及各种生物功能的蛋白质编码基因的失调与甲状腺癌的进展密切相关。本研究旨在探讨失调基因表达对经典型甲状腺乳头状癌(cPTC)预后的影响。我们使用来自癌症基因组图谱(TCGA)数据库的表达谱数据集进行差异表达分析,以鉴定差异表达基因(DEGs)。Cox 回归和 Kaplan-Meier 分析用于鉴定 DEGs,这些基因用于构建风险模型,以预测 cPTC 患者的预后。功能富集分析揭示了肿瘤中共同表达的蛋白质编码基因的潜在意义。我们鉴定了 4 个 DEGs(SALL3、PPBP、MYH1 和 SYNDIG1),这些基因用于构建风险模型,以预测 cPTC 患者的预后。这些 4 个基因独立于临床参数,可能在 cPTC 癌变中具有功能。此外,PPBP 在疾病晚期与更差的总生存期(OS)具有很强的相关性。这项研究表明,4 基因特征可能是改善 46 岁以上 cPTC 患者预后预测的独立预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/d333404fc2a0/medi-103-e38472-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/50c729ad4216/medi-103-e38472-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/c93dbb83c008/medi-103-e38472-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/7a692bc266de/medi-103-e38472-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/68d7a7e3a244/medi-103-e38472-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/8226da4e7c30/medi-103-e38472-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/d641d1114776/medi-103-e38472-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/d333404fc2a0/medi-103-e38472-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/50c729ad4216/medi-103-e38472-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/c93dbb83c008/medi-103-e38472-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/7a692bc266de/medi-103-e38472-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/68d7a7e3a244/medi-103-e38472-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/8226da4e7c30/medi-103-e38472-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/d641d1114776/medi-103-e38472-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5408/11155612/d333404fc2a0/medi-103-e38472-g007.jpg

相似文献

1
Prognostic prediction of patients having classical papillary thyroid carcinoma with a 4 mRNA-based risk model.基于 4 个 mRNA 的风险模型预测经典型甲状腺乳头状癌患者的预后。
Medicine (Baltimore). 2024 Jun 7;103(23):e38472. doi: 10.1097/MD.0000000000038472.
2
Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.开发和验证铁死亡相关的预后模型,用于预测甲状腺乳头状癌患者的无进展生存期和免疫微环境。
Int Immunopharmacol. 2021 Dec;101(Pt A):108156. doi: 10.1016/j.intimp.2021.108156. Epub 2021 Oct 6.
3
Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis.差异表达基因和长非编码 RNA 在甲状腺乳头状癌诊断、进展和预后中的作用。
J Cell Biochem. 2018 Nov;119(10):8249-8259. doi: 10.1002/jcb.26836. Epub 2018 Jul 3.
4
Low expression of  in papillary thyroid carcinoma may correlate with poor prognosis but high immune cell infiltration.在甲状腺乳头状癌中低表达可能与不良预后相关,但免疫细胞浸润较高。
Future Oncol. 2022 Jan;18(3):333-348. doi: 10.2217/fon-2020-1183. Epub 2021 Nov 10.
5
Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.鉴定脂质代谢相关基因作为甲状腺乳头状癌的预后指标。
Acta Biochim Biophys Sin (Shanghai). 2021 Dec 8;53(12):1579-1589. doi: 10.1093/abbs/gmab145.
6
Correlation between telomerase reverse transcriptase messenger RNA expression and survival of patients with papillary thyroid carcinoma.端粒酶逆转录酶信使 RNA 表达与甲状腺乳头状癌患者生存的相关性。
Surgery. 2021 Jan;169(1):43-49. doi: 10.1016/j.surg.2020.04.054. Epub 2020 Jul 5.
7
A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.代谢相关列线图预测甲状腺癌复发生存。
Curr Med Sci. 2021 Oct;41(5):1004-1011. doi: 10.1007/s11596-021-2399-x. Epub 2021 Sep 2.
8
MicroRNA signature predicts survival in papillary thyroid carcinoma.微小RNA特征可预测甲状腺乳头状癌的生存率。
J Cell Biochem. 2019 Oct;120(10):17050-17058. doi: 10.1002/jcb.28966. Epub 2019 May 17.
9
lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.长链非编码 RNA DUXAP8 通过海绵吸附 miR-20b-5p/SOS1 轴抑制甲状腺乳头状癌细胞凋亡。
Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8015. Epub 2021 Mar 24.
10
The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma.甲状腺分化评分与乳头状甲状腺癌生存结果之间的关联
J Clin Endocrinol Metab. 2025 Jan 21;110(2):356-363. doi: 10.1210/clinem/dgae532.

本文引用的文献

1
Genetic estimation of correlations between circulating glutamine and cancer.循环谷氨酰胺与癌症之间相关性的遗传估计
Am J Cancer Res. 2023 Dec 15;13(12):6072-6089. eCollection 2023.
2
Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC.分析头颈鳞状细胞癌中的肌球蛋白基因,并鉴定 MYL1 作为一个特定的不良预后生物标志物,促进头颈鳞状细胞癌中的肿瘤转移,并与肿瘤免疫浸润相关。
BMC Cancer. 2023 Sep 7;23(1):840. doi: 10.1186/s12885-023-11349-5.
3
Anti-HPV16 oncoproteins siRNA therapy for cervical cancer using a novel transdermal peptide PKU12.
使用新型透皮肽PKU12进行抗人乳头瘤病毒16型癌蛋白小干扰RNA治疗宫颈癌
Front Oncol. 2023 Jun 7;13:1175958. doi: 10.3389/fonc.2023.1175958. eCollection 2023.
4
Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma.基于数据挖掘的头颈部鳞癌诊断和预后生物标志物鉴定
Sci Rep. 2023 Jun 20;13(1):10020. doi: 10.1038/s41598-023-37216-8.
5
Induction of filopodia formation by α-Actinin-2 via RelA with a feedforward activation loop promoting overt bone marrow metastasis of gastric cancer.α-辅肌动蛋白-2 通过 RelA 形成的伪足诱导作用,具有促进胃癌明显骨髓转移的前馈激活环。
J Transl Med. 2023 Jun 19;21(1):399. doi: 10.1186/s12967-023-04156-w.
6
Construction of a TTN Mutation-Based Prognostic Model for Evaluating Immune Microenvironment, Cancer Stemness, and Outcomes of Colorectal Cancer Patients.构建基于TTN突变的预后模型以评估结直肠癌患者的免疫微环境、癌症干性和预后
Stem Cells Int. 2023 Feb 21;2023:6079957. doi: 10.1155/2023/6079957. eCollection 2023.
7
Age-dependent changes in the prognostic advantage of papillary thyroid cancer in women: A SEER-based study.基于 SEER 数据库的研究:女性甲状腺乳头状癌预后优势与年龄的相关性变化。
Clin Endocrinol (Oxf). 2023 Sep;99(3):342-349. doi: 10.1111/cen.14896. Epub 2023 Feb 24.
8
High frequency of KRAS and EGFR mutation profiles in BRAF-negative thyroid carcinomas in Indonesia.印度尼西亚 BRAF 阴性甲状腺癌中 KRAS 和 EGFR 突变谱的高频。
BMC Res Notes. 2022 Dec 12;15(1):369. doi: 10.1186/s13104-022-06260-4.
9
Expression of , and in colon cancer and their influences on prognosis.[具体基因名称]、[具体基因名称]和[具体基因名称]在结肠癌中的表达及其对预后的影响。 (你提供的原文中基因名称缺失,我按格式补充了相关内容以便理解)
Transl Cancer Res. 2022 Oct;11(10):3572-3583. doi: 10.21037/tcr-22-1377.
10
TTN mutations predict a poor prognosis in patients with thyroid cancer.TTN 突变可预测甲状腺癌患者的不良预后。
Biosci Rep. 2022 Jul 29;42(7). doi: 10.1042/BSR20221168.